Heading up to the next session to discuss exciting advancements in kidneycancer. GU19pic.twitter.comBtyNaUcplY

Heading up to the next session to discuss exciting advancements in #kidneycancer. #GU19pic.twitter.com/BtyNaUcplY

13:32 EST 16 Feb 2019 | Merck & Co., Inc.

Heading up to the next session to discuss exciting advancements in #kidneycancer. #GU19 pic.twitter.com/BtyNaUcplY

More From BioPortfolio on "Heading up to the next session to discuss exciting advancements in #kidneycancer. #GU19pic.twitter.com/BtyNaUcplY"